top of page

PE-22-28


  • Peptide: PE-22-28

  • Bottle Dose: 10mg

  • Vial Capacity: 3mL


Storage

  • Before mixing: Refrigerate powder and bacteriostatic water for at least 1 hour

  • After mixing: Store reconstituted solution in refrigerator at all times

  • Use within 20–30 days of reconstitution

Reconstitution

  • Add: 2mL of bacteriostatic water

Conversion Table (If 2mL of bac water is added)

Units (on 100 unit insulin syringe)             Dose (mcg)

2 units                                                                     100mcg

4 units                                                                    200mcg

6 units                                                                    300mcg                                            10 units                                                                 500mcg


Dosage Amount

  • Typical starting dose:
    100mcg (2 units) to 500mcg (10 units) daily. 

(This is where that note will go about doseages and finding their own dose by starting low and tirtrating upwards.))



Injection Schedule

  • Frequency: Once daily

  • Time: Morning or early evening

  • Route: Subcutaneous (belly fat or thigh)

Protocol Duration

  • Standard cycle: 4–6 weeks

  • Break: 2–4 weeks off before repeating (to prevent receptor desensitization)



Injection Notes

  • Rotate injection sites

  • Use 29–31 gauge insulin syringes

  • Morning administration may enhance mood and mental clarity




PE-22-28- is a short peptide fragment derived from DBI that modulates GABA-A receptors in the brain. It is non-sedative, non-addictive, and designed to mimic the anti-anxiety effects of benzodiazepines without their side effects or dependency risk.

Mechanism of Action

  • Acts on GABA-A receptors at an allosteric site (similar to benzodiazepines but with different binding kinetics)

  • Enhances GABAergic transmission, promoting calming and anxiolytic effects

  • Does not bind directly to benzodiazepine receptor site, reducing potential for sedation or tolerance

Top Benefits of PE-22-28

🧠 Neurological & Cognitive Benefits

  • Reduces anxiety without sedation or addiction potential

  • Improves mood by enhancing GABA tone and balancing neurotransmitters

  • Supports neurogenesis and neuronal plasticity

  • Protects against neuroinflammation and oxidative stress

  • May improve emotional resilience and stress tolerance

😴 Sleep & Relaxation

  • Promotes relaxation and calm without causing drowsiness

  • May improve sleep quality by reducing cortisol-driven arousal

🧬 Neuroprotective Effects

  • Protects brain tissue from glutamate-induced excitotoxicity

  • May aid in recovery from brain injuries, PTSD, or chronic stress states

💊 Alternative to Benzodiazepines

  • Non-habit-forming and non-sedating

  • No withdrawal symptoms reported in research settings

  • May be a safe long-term option for anxiety management

Emerging Research & Applications

  • PTSD, social anxiety, and generalized anxiety disorders (GAD)

  • Adjunct for traumatic brain injury recovery

  • Neurodegenerative disease prevention (being studied)

  • Cognitive enhancement under high-stress conditions

bottom of page